Category Specific RSS

maxigesic

AFT Pharmaceuticals locks in $9.4 million agreement after US FDA approves pain relief drug Maxigesic IV

For the second time this year, pharma company AFT Pharmaceuticals (ASX: AFP) has bagged the US Food and Drug Administration’s…

2 years ago

AFT’s pain relief medication Maxigesic gets FDA approval, but the IV version still under scrutiny

Maxigesic’s tagline goes: Put it to the test for your pain. Its maker—pharma company AFT Pharmaceuticals (ASX: AFP) —did indeed…

2 years ago

High Court sides with AFT Pharmaceuticals after Nurofen maker dispute

Sticks and stones may break my bones but words may result in legal action because they can be misconstrued despite…

3 years ago

AFT Pharmaceuticals gains regulatory approval for new form of pain medication

Fresh off their recent distribution success of their intravenous, non-opioid based pain medication, AFT Pharmaceuticals (ASX: AFP) has ticked another…

4 years ago

Could this pharma company hold the answer to overuse of opioids?

Pain management is one of the most fascinating arms of medicine. Post-operative pain management, even more so. Practitioners must strike…

4 years ago